Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells

To enhance the anticancer efficacy of gemcitabine in the treatment of non-small cell lung cancer (NSCLC), the potential synergistic effect of piceatannol on gemcitabine cytotoxicity was investigated in the human NSCLC A459 cell line. The MTT cell viability assay showed that piceatannol significantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bin, Tao, Ze-Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838451/
https://www.ncbi.nlm.nih.gov/pubmed/26351210
http://dx.doi.org/10.3727/096504015X14386062091398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838451/
https://www.ncbi.nlm.nih.gov/pubmed/26351210
http://dx.doi.org/10.3727/096504015X14386062091398

Ejemplares similares